Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 5, p. 209, doi. 10.1038/cgt.2014.20
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2014 AND VI 21 AND IP 5
Results: 6
1
2
Human placenta mesenchymal stem cells expressing exogenous kringle1-5 protein by fiber-modified adenovirus suppress angiogenesis.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 5, p. 200, doi. 10.1038/cgt.2014.19
- By:
- Publication type:
- Article
3
The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 5, p. 188, doi. 10.1038/cgt.2014.16
- By:
- Publication type:
- Article
4
Epithelial-to-mesenchymal transition and cancer stem cells: emerging targets for novel cancer therapy.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 5, p. 179, doi. 10.1038/cgt.2014.17
- By:
- Publication type:
- Article
5
Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 5, p. 181, doi. 10.1038/cgt.2014.15
- By:
- Publication type:
- Article
6
Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 5, p. 194, doi. 10.1038/cgt.2014.18
- By:
- Publication type:
- Article